STOCK TITAN

Ingevity (NGVT) CAO granted 2,063 RSUs vesting in 2027-2029

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Cotterman Ryan Joseph reported acquisition or exercise transactions in this Form 4 filing.

Ingevity Corp reported that VP and Chief Accounting Officer Ryan Joseph Cotterman received an equity grant of 2,063 shares of common stock as a compensation award. The grant represents restricted stock units under the Ingevity Corporation 2025 Omnibus Incentive Plan, issued at no cash cost to him.

These restricted stock units will vest in three equal installments on June 22, 2027, 2028, and 2029, tying part of his compensation to future service and company performance. Following this award, Cotterman directly holds 2,063 shares linked to this grant.

Positive

  • None.

Negative

  • None.
Insider Cotterman Ryan Joseph
Role VP, Chief Accounting Officer
Type Security Shares Price Value
Grant/Award Common Stock 2,063 $0.00 --
Holdings After Transaction: Common Stock — 2,063 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Equity grant size 2,063 shares Restricted stock units granted to VP and CAO
Grant price per share $0.00 per share Restricted stock unit award, not open-market purchase
Shares held after transaction 2,063 shares Direct holdings following the grant
First vesting date June 22, 2027 First of three equal annual vesting installments
Second vesting date June 22, 2028 Second vesting installment for the RSU grant
Third vesting date June 22, 2029 Final vesting installment for the RSU grant
restricted stock units financial
"Grant of restricted stock units pursuant to the Ingevity Corporation 2025 Omnibus Incentive Plan"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Omnibus Incentive Plan financial
"pursuant to the Ingevity Corporation 2025 Omnibus Incentive Plan, as amended"
An omnibus incentive plan is a single, flexible program a company uses to give employees and executives different types of pay tied to performance — for example stock options, restricted shares, cash bonuses and other awards — all governed by one set of rules. It matters to investors because it determines how many new shares may be created, how leaders are motivated and how much the company will spend on compensation over time; think of it as a master toolbox that affects both costs and the total share supply.
Form 4 regulatory
"INSIDER FILING DATA (Form 4)"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
Chief Accounting Officer financial
"officer_title": "VP, Chief Accounting Officer""
A chief accounting officer is a senior executive responsible for overseeing a company's financial records and ensuring all accounting practices are accurate and compliant with regulations. They play a key role in preparing financial reports that help investors understand the company's financial health, much like a trusted navigator guiding a ship through complex waters. Their work ensures transparency and trust in the company's financial information.
non-derivative financial
"transaction_type": "non-derivative""
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Cotterman Ryan Joseph

(Last)(First)(Middle)
C/O INGEVITY CORPORATION
4920 O'HEAR AVENUE, SUITE 400

(Street)
NORTH CHARLESTON SOUTH CAROLINA 29405-4986

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Ingevity Corp [ NGVT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
VP, Chief Accounting Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/22/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/22/2026A2,063(1)A$02,063D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Grant of restricted stock units pursuant to the Ingevity Corporation 2025 Omnibus Incentive Plan, as amended, which will vest in three equal installments on June 22, 2027, 2028, and 2029.
Remarks:
Ryan J. Cotterman By: Mavis Huger as Attorney-in-Fact06/24/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Ingevity (NGVT) report for Ryan Joseph Cotterman?

Ingevity reported that VP and Chief Accounting Officer Ryan Joseph Cotterman received an equity award of 2,063 restricted stock units. The grant is a compensation award under the 2025 Omnibus Incentive Plan and does not reflect an open-market stock purchase.

How many shares were granted to the Ingevity (NGVT) CAO in this Form 4?

The Form 4 shows a grant of 2,063 restricted stock units tied to Ingevity common stock. These units were awarded at a price of $0.00 per share as part of equity compensation, rather than being bought on the open market.

What is the vesting schedule for the 2,063 restricted stock units at Ingevity (NGVT)?

The 2,063 restricted stock units vest in three equal annual installments on June 22, 2027, June 22, 2028, and June 22, 2029. This schedule encourages continued employment and aligns the executive’s long-term incentives with shareholders over several years.

Did the Ingevity (NGVT) CAO pay cash for the shares reported in this Form 4?

No, the shares were granted at a transaction price of $0.00 per share as restricted stock units. This indicates a compensation-related award, not a cash-funded stock purchase, and is typical of long-term incentive plans for senior executives.

How many Ingevity (NGVT) shares does the CAO hold after this equity grant?

After the reported grant, Ryan Joseph Cotterman directly holds 2,063 shares associated with this award. The Form 4 does not show additional derivative positions, indicating this particular filing focuses on the new restricted stock unit grant.